27 May 2022
Andrey Chesnokov, the head of the administration of the Starooskolsky municipal district, held a working meeting with the management of OOO Amegen and representatives of resource-supplying organizations on the implementation of the investment project called “Production of Enoxaparin sodium (pharmaceutical substance)”. This was reported in the press service of Stary Oskol administration.
“The substance is used as the basis for the production of anticoagulants used for cardiovascular diseases. It is important to note that the project is import-substituting. During the meeting, the participants also discussed the roadmap of the project and some technical issues,” the message reads.
Earlier, it became known that Amegen plans to raise 100 million rubles to organize the first high-tech import-substituting production of Enoxaparin sodium pharmaceutical substance for the production of therapies for cardiovascular diseases in Russia.
Altai State University researchers are developing a pharmaceutical substance for lung diseases therapy.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024